4//SEC Filing
Prokupets Elena 4
Accession 0001209191-21-057633
CIK 0001662579other
Filed
Sep 23, 8:00 PM ET
Accepted
Sep 24, 4:51 PM ET
Size
19.3 KB
Accession
0001209191-21-057633
Insider Transaction Report
Form 4
Prokupets Elena
Director
Transactions
- Sale
Common Stock
2021-09-23$51.08/sh−1,007$51,435→ 506,552 total(indirect: By ERP Business Holdings, LP) - Sale
Common Stock
2021-09-24$50.10/sh−2,115$105,964→ 504,437 total(indirect: By ERP Business Holdings, LP) - Sale
Common Stock
2021-09-22$50.10/sh−3,544$177,554→ 39,492 total(indirect: By Spouse) - Sale
Common Stock
2021-09-23$50.35/sh−5,926$298,359→ 33,566 total(indirect: By Spouse) - Sale
Common Stock
2021-09-22$50.09/sh−7,004$350,860→ 519,360 total(indirect: By ERP Business Holdings, LP) - Sale
Common Stock
2021-09-23$51.09/sh−446$22,784→ 33,120 total(indirect: By Spouse) - Sale
Common Stock
2021-09-23$50.35/sh−11,801$594,193→ 507,559 total(indirect: By ERP Business Holdings, LP) - Sale
Common Stock
2021-09-24$50.11/sh−900$45,101→ 32,220 total(indirect: By Spouse)
Footnotes (9)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 12, 2021.
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $50.00 to $50.31. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- [F3]This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 15, 2021.
- [F4]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $50.00 to $50.34. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- [F5]Shares held by ERP Business Holdings, L.P. The Reporting Person disclaims beneficial ownership of these shares except to the extent of her pecuniary interest therein.
- [F6]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $50.00 to $50.99. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- [F7]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $51.04 to $51.16. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- [F8]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $51.00 to $51.16. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- [F9]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $50.00 to $50.28. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Documents
Issuer
C4 Therapeutics, Inc.
CIK 0001662579
Entity typeother
Related Parties
1- filerCIK 0001824823
Filing Metadata
- Form type
- 4
- Filed
- Sep 23, 8:00 PM ET
- Accepted
- Sep 24, 4:51 PM ET
- Size
- 19.3 KB